Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


qazinform.com > news > almaty-oncology-center-introduces-robotic-pharmacy-system-90e08e

Almaty oncology center introduces robotic pharmacy system

1+ week, 1+ day ago   (220+ words) A robotic pharmacy system and a closed, airtight drug preparation system have been introduced at the Almaty oncology center, Qazinform News Agency reports, citing the Ministry of Healthcare of the Republic of Kazakhstan. The new technology automates the key stages…...


qazinform.com > news > kazakhstan-deploys-drones-to-release-beneficial-insects-onto-crops-085f69

Kazakhstan deploys drones to release beneficial insects onto crops

1+ week, 5+ day ago   (132+ words) The technology, called BioDrop, helps increase the biological efficiency of crop protection. Drones release capsules along a pre-programmed route; once on the ground, insects gradually emerge and begin targeting pests. Drone distribution is four to six times faster than manual…...


qazinform.com > news > how-unstable-work-hours-affect-men-and-women-differently-6a47a6

How unstable work hours affect men and women differently

2+ week, 3+ day ago   (254+ words) Unpredictable changes in working hours may take a toll on workers’ health, but the effects differ for men and women, according to a new U.S. study, Qazinform News Agency correspondent reports. Researchers from the University of Illinois Urbana-Champaign examined data…...


qazinform.com > news > moderna-merck-cancer-vaccine-succeeds-in-phase-3-trial-d30b44

Moderna, Merck cancer vaccine succeeds in Phase 3 trial

3+ week, 4+ day ago   (338+ words) Moderna and Merck have announced positive Phase 3 results for their personalized mRNA cancer treatment Intismeran in patients with high-risk melanoma, marking a major milestone for mRNA-based cancer therapies, reports a Qazinform News Agency correspondent. The companies said the Phase 3 INTerpath…...